Concepedia

Daphne Guinn

DG

Statistics

Publications

15

Citations

986

H-Index

12

Active since

2011

Affiliations

The Ohio State University(Current)

Georgetown University

Ashland University

United States Food and Drug Administration

American Association of Colleges of Pharmacy

Daphne Guinn is an author at The Ohio State University specializing in pharmacy, cancer immunotherapy, and oncology.

ORCID

Publications per year

2011–2023

15

Publications

15

<i>BTK</i><sup>C481S</sup>-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Jennifer A. Woyach, Amy S. Ruppert, Daphne Guinn et al. · Journal of Clinical Oncology · 2017 · 471 citations

, , +16

IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells

Shuai Dong, Daphne Guinn, Jason A. Dubovsky et al. · Blood · 2014 · 99 citations · Full text

, , +16

Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia

Zachary A. Hing, Rose Mantel, Kyle A. Beckwith et al. · Blood · 2015 · 95 citations · Full text

, , +7

Roadmap to 2030 for Drug Evaluation in Older Adults

Qi Liu, Janice B. Schwartz, Patricia W. Slattum et al. · Clinical Pharmacology & Therapeutics · 2021 · 66 citations · Full text

, , +13

Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL

Sean D. Reiff, Elizabeth M. Muhowski, Daphne Guinn et al. · Blood · 2018 · 64 citations · Full text

, , +15

1–5 of 15